(TSX:BLCO)

24.74 UNCHANGED

Delayed Quote Updated: 3:58 PM EDT, Oct 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BLCO

< Previous 1 2 3 4 5 6 Next >

Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States

May 21, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United States

May 14, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens

May 07, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces First-Quarter 2025 Results

April 30, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Returning enVista® Intraocular Lenses to Market Following Voluntary Recall

April 24, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Voluntary Recall of enVista Aspire™, enVista Envy™ and Certain enVista® Monofocal Intraocular Lenses

March 27, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30

March 26, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Launches Arise™ Orthokeratology Lens System in the United States

March 17, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance

February 19, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Provides Update on Potential Sale

February 06, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19

January 22, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences

January 13, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union

January 13, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge

January 07, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

January 02, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Responds to Rumors of a Potential Sale

December 12, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

December 11, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

November 14, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Third-Quarter 2024 Results

October 30, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens

October 14, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30

October 09, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Launches Opal™ Digital Marketplace in the United States

October 01, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Second-Quarter 2024 Results

July 31, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31

July 11, 2024

From Bausch + Lomb Corporation

Via Business Wire

Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief

July 08, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress

June 17, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States

June 10, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States

June 03, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results

May 29, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®

May 28, 2024

From Bausch + Lomb Corporation

Via Business Wire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.